Skip to main content
. 2017 Jul 31;8(41):70431–70440. doi: 10.18632/oncotarget.19712

Figure 4. ROC curves analysis of NKA-IFNγ, CEA, and CA19-9 assays to discriminate healthy donors from gastric cancer (GC) patients (A) and early GC patients (B).

Figure 4